1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "2206788-99-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-125836
    CCR4 antagonist 2

    CCR Cancer Endocrinology
    CCR4 antagonist 2 (Compound 31) is a novel potent, orally bioavailable small molecule antagonists of CC chemokine receptor 4 (CCR4) that inhibits Treg trafficking into the Tumor Microenvironment without suppressing the number of Treg in healthy tissues. CCR4 antagonist 2 (Compound 31) exhibits IC50 values of Ca 2+flux and (chemotaxis) CTX are 40 nM and 70 nM, respectively.